Viewing Study NCT07059494


Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2025-12-26 @ 12:05 AM
Study NCT ID: NCT07059494
Status: RECRUITING
Last Update Posted: 2025-11-04
First Post: 2025-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
Sponsor: Icahn School of Medicine at Mount Sinai
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module